miRNA-22 attenuates microglial pyroptosis by targeting GSDMD, reducing NLRP3 inflammasome activation and inflammatory cytokine expression, and significantly improving memory and motor function in an APP/PS1 double-transgenic AD mouse model (Han et al., 2020). The gene discussed is GSDMD; the disease is Alzheimer disease.